Squarepoint
COGT icon

Squarepoint’s Cogent Biosciences COGT Stock Holding History

Squarepoint’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-226,259
Closed -$8.71M – 4487
2026
Q1 		$8.71M Buy
226,259
+70,275
+45% +$2.59M 0.01% 1147
2025
Q4 		$5.54M Buy
+155,984
New +$4.38M 0.01% 1393
2025
Q3 		– Sell
-101,518
Closed -$729K – 4437
2025
Q2 		$729K Buy
+101,518
New +$563K ﹤0.01% 2934
2025
Q1 		– Sell
-128,799
Closed -$1M – 4696
2024
Q4 		$1M Buy
128,799
+117,939
+1,086% +$1.18M ﹤0.01% 3061
2024
Q3 		$117K Buy
+10,860
New +$106K ﹤0.01% 3839
2024
Q2 		– Sell
-16,843
Closed -$113K – 4135
2024
Q1 		$113K Buy
16,843
+566
+3% +$3.5K ﹤0.01% 3775
2023
Q4 		$95.7K Buy
+16,277
New +$125K ﹤0.01% 3760
2023
Q2 		– Sell
-25,958
Closed -$280K – 3621
2023
Q1 		$280K Sell
25,958
-37,192
-59% -$476K ﹤0.01% 2615
2022
Q4 		$730K Buy
+63,150
New +$783K ﹤0.01% 2048
2022
Q1 		– Sell
-10,475
Closed -$90K – 2916
2021
Q4 		$90K Buy
+10,475
New +$91.1K ﹤0.01% 2942
2021
Q2 		– Sell
-10,290
Closed -$90K – 3286
2021
Q1 		$90K Sell
10,290
-1,982
-16% -$19.1K ﹤0.01% 2920
2020
Q4 		$138K Sell
12,272
-12,067
-50% -$133K ﹤0.01% 2635
2020
Q3 		$228K Buy
+24,339
New +$254K ﹤0.01% 2002
2018
Q4 		– Sell
-4,850
Closed -$200K – 1978
2018
Q3 		$200K Buy
+4,850
New +$273K ﹤0.01% 1775

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Squarepoint's COGT Position: Q2 2026 in Review

Squarepoint sold out of Cogent Biosciences (COGT) in Q2 2026, closing a stake of 226,259 shares — an estimated $8.71M sold.

Squarepoint first reported a position in COGT in Q3 2018 and held it in 14 quarters. The position peaked at $8.71M in Q1 2026. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Squarepoint reported no remaining Cogent Biosciences position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 226,259 Cogent Biosciences shares in Q2 2026, an estimated $8.71M.
  • Squarepoint first reported a position in Cogent Biosciences in Q3 2018 and held it in 14 quarters.
  • Squarepoint's Cogent Biosciences position peaked at $8.71M in Q1 2026.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.